Pharmaceutical product development and manufacturing is in serious need of technical upgrading particularly as regards :

• Biopharmaceutical challenges : administration of poorly soluble, high-potent and specific APIs, specific-site and/or sustained release delivery, delivery of challenging protein therapeutics…


• Market challenges : time to market for new drugs, life-cycle management of soon off-patent drug.

Most of these challenges are related to the engineering of stable drug particles or drug-loaded particles exhibiting a strictly controlled dosage, solid state morphology and particle size distribution.